title: Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.
authors.affiliation: Rambam Medical Center, Haifa, Israel. b_brenner@rambam.health.gov.il
authors.forename: B
authors.initials: B
authors.lastname: Brenner
authors.forename: R
authors.initials: R
authors.lastname: Hoffman
authors.forename: H
authors.initials: H
authors.lastname: Carp
authors.forename: M
authors.initials: M
authors.lastname: Dulitsky
authors.forename: J
authors.initials: J
authors.lastname: Younis
mesh_terms: D000026:Abortion, Habitual / Q000188:drug therapy / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity; D017984:Enoxaparin / Q000008:administration & dosage* / Q000633:toxicity; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D011256:Pregnancy Outcome; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight